The Form 4 filing, an SEC report of an insider's stock transactions, was filed on November 18, 2026. It covers trades made on November 16. Mark E. Bertels serves as CorVel's executive vice president of Risk Management Services.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-16 |
| Date of Latest Transaction | 2026-11-16 |
| Buy/Sell | sell |
| Transaction Count | 3 |
| Shares Transacted | 5,847 |
| Price | $87.50 |
| Total Transaction Value | $511,612.50 |
| Insider | |
| Ticker Symbol | CRVL |
| Company | CORVEL CORP |
| Insider Name | Bertels Mark E. |
| Insider Title | EVP - Risk Management Services |
| Sector - Industry | Financial Services - Insurance Brokers |
| Holdings | |
| Total Shares Owned After Transaction | 2,918 |
| Position Size Change | 66.71% |
| Filing | |
| Filing Date | 2026-11-18 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a sale of CRVL shares, reported with transaction code S. The transaction details also link it to an exercise or conversion. That can involve using a right to buy shares or changing another type of investment into shares.
What was the average price of the transaction?
The average sale price was $87.50 per share across the three transactions.
How did this transaction affect the insider's holdings?
After selling 5,847 shares, he reported 2,918 shares still owned. The sale accounted for 66.71% of the shares held before the sale, based on the reported balance.
What's the total transaction value?
The total value was $511,612.50 for all three sales combined.
Are there any special circumstances around this transaction?
Yes. The sale was matched by share count with an M-coded acquisition in the same filing. Code M identifies shares received through an exercise or conversion. This points to a related sale, but the acquisition's full details were not provided.
Matching counts do not confirm matching dates, share types or accounts. They also do not prove that the same shares received were sold. The filing's footnote text was not provided, so the exact terms remain unknown.
For research purposes only; not investment advice.